Nearly 300 aspiring biomedical researchers expressed interest in a program that pairs students with Sylvester Comprehensive Cancer Center faculty in the lab.| Florida Academic Cancer Center Alliance
The drug olutasidenib targets a mutation linked to some cases of MDS, a potentially deadly condition that can progress to leukemia.| InventUM
A new study shows how a key molecule regulates the generation of new blood cells. The findings could lead to new therapeutic strategies targeting the molecule.| Florida Academic Cancer Center Alliance
Powerlifter LaShae Rolle developed a training routine that fit with her breast cancer treatment.| InventUM
Sylvester Comprehensive Cancer Center is leading a groundbreaking initiative designed to transform survivorship care in community health centers across South Florida.| Florida Academic Cancer Center Alliance
The ADVANCE clinical trial compares a new four-drug combination treatment (DKRd) with a three-drug treatment (KRd) for multiple meyeloma.| InventUM
University of Miami Miller School of Medicine - Research, Education & Medical News| InventUM
Sylvester researchers contributed to two tumor profiling studies classifying glioblastomas and describing how they evolve after treatment.| InventUM